News Medical on MSN
Development of therapeutic cancer vaccines based on cancer immunity cycle
Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...
Q3 2025 Earnings Call Transcript November 14, 2025 MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Schizophrenia is a serious psychiatric disorder that affects how people feel, think, and behave. It impacts approximately 1% ...
Scientists from Tianjin University have made a groundbreaking advancement in cancer therapeutics by developing an oral "microbial fuel cell" capsule. This innovative platform, activated by ...
A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to ...
Detailed price information for Mink Therapeutics Inc (INKT-Q) from The Globe and Mail including charting and trades.
The announcement comes at a critical time when late-stage pancreatic cancer remains a formidable challenge due to its silent progression and limited treatment options in many regions. By streamlining ...
The transcription factor HEB synergizes with TCR signaling to upregulate Id3, which is required for the maturation of fetal IL-17-producing γδ T cells.
All brelovitug dose regimens studied were well tolerated Results will be presented at The Liver Meeting® 2025 of AASLDAdditional preclinical data ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果